Nuwellis, Inc. (NASDAQ:NUWE – Free Report) – Roth Capital dropped their Q1 2025 earnings estimates for Nuwellis in a report released on Tuesday, March 11th. Roth Capital analyst J. Aschoff now anticipates that the company will post earnings per share of ($0.45) for the quarter, down from their prior estimate of ($0.30). The consensus estimate for Nuwellis’ current full-year earnings is ($8.17) per share. Roth Capital also issued estimates for Nuwellis’ Q2 2025 earnings at ($0.36) EPS, Q3 2025 earnings at ($0.35) EPS, Q4 2025 earnings at ($0.28) EPS, FY2025 earnings at ($1.39) EPS, FY2026 earnings at ($0.52) EPS, FY2027 earnings at $0.09 EPS, FY2028 earnings at $0.78 EPS and FY2029 earnings at $1.41 EPS.
Nuwellis Price Performance
Shares of NUWE opened at $1.15 on Thursday. The firm has a market capitalization of $5.03 million, a PE ratio of -0.01 and a beta of 0.36. The company’s fifty day moving average price is $1.22 and its 200-day moving average price is $1.34. Nuwellis has a 1-year low of $0.92 and a 1-year high of $16.63.
Institutional Trading of Nuwellis
About Nuwellis
Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.
Further Reading
- Five stocks we like better than Nuwellis
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- 3 Undervalued Stocks You Can Buy at a Discount Now
- EV Stocks and How to Profit from Them
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- Comparing and Trading High PE Ratio Stocks
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for Nuwellis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuwellis and related companies with MarketBeat.com's FREE daily email newsletter.